基本情報
- CAS
97165-77-0- 標準SMILES
N#Cc1cc(Br)cc(Br)c1- InChIKey
QUJGDNCWTBTBQD-UHFFFAOYSA-N- 分子式
- C7H3Br2N
- 平均分子量
- 260.91 g/mol
- 単同位体質量
- 258.8632233
名称と識別子
- 優先名称
- 3,5-Dibromobenzonitrile
- IUPAC
- 3,5-dibromobenzonitrile
- 現地名
- 3,5-ジブロモベンゾニトリル
- 英語名
- 3,5-DIBROMOBENZONITRILE
- 分子式
- C7H3Br2N
- 分子量
- 260.91
名称と別名
名称をさらに表示
データベース識別子
- CAS
97165-77-0- PubChem CID
- 2797690
- DTXSID
DTXSID80383944- EC Number
- 806-988-7
- Nikkaji
- J3.002.927E
物性
構造計算による物性
- XLogP
- 3
- 極性表面積
- 23.8 Ų
- 水素結合供与体数
- 0
- 水素結合受容体数
- 1
- 回転可能結合数
- 0
- 重原子数
- 10
- 形式電荷
- 0
- 複雑度
- 150
物理化学的性質
- 融点
- 98 °C · 98 °C
- 沸点
- 261.2 · 261.2±20.0 °C(Predicted)
- 比重(密度)
- 2.06 · 2.06±0.1 g/cm3(Predicted)
- 貯蔵温度
- 2 · under inert gas (nitrogen or Argon) at 2-8°C
- 溶解性
- soluble in Methanol
- 外見
- powder to crystal
- 色
- White to Light yellow
- InChI
- InChI=1S/C7H3Br2N/c8-6-1-5(4-10)2-7(9)3-6/h1-3H
- InChIKey
- QUJGDNCWTBTBQD-UHFFFAOYSA-N
- SMILES
- C(#N)C1=CC(Br)=CC(Br)=C1
- CAS データベース
- 97165 · 97165-77-0(CAS DataBase Reference)
安全と法規制
GHS分類
GHS Classification
Danger
H301 (25%): Toxic if swallowed [Danger Acute toxicity, oral]
P261, P262, P264, P264+P265, P270, P271, P280, P301+P316, P301+P317, P302+P352, P304+P340, P305+P351+P338, P316, P317, P319, P321, P330, P332+P317, P337+P317, P361+P364, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 4 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
危険有害性情報
安全データ
- ridadr
- 3276
- hs_code
- 29269090
- risk_code
- 20/21/22-36/37/38
- hazard_code
- Xi
- safety_code
- 26-36/37/39-36-23-22-4
- hazard_class
- IRRITANT
- 毒劇物取締法
- 劇物
化学と産業
応用分野
使用3,5-Dibromobenzonitrile is a chemical compound that can be found at high concentrations in the brain of patients with neurodegenerative diseases. 3,5-Dibromobenzonitrile has been shown to bind to metabotropic glutamate receptor 5 (mGluR5) and activate it; it also binds to glutamate receptors. The uptake of 3,5-dibromobenzonitrile by the body is dependent on its molecular orbital type and the functional groups present. Brain tissue samples from patients with neurodegenerative diseases have shown an increase in the amount of 3,5-dibromobenzonitrile binding to mGluR5. This increased binding may be due to a change in the molecular orbitals or functional groups on mGluR5, as well as an increase in expression of this receptor in diseased brains.
上流・下流製品情報
上流原料
下流製品
サプライヤー100 社
関連反応
化合物ノート
読み込み中…